Volume 12 Supplement 1
17th International Conference on Human Retroviruses: HTLV and Related Viruses
Meeting abstracts
Edited by Raymond Cesaire, Agnès Lézin and Jean-Marie Péloponèse Jr
Publication of this supplement was funded by EU PO-FEDER of Martinique. The Supplement Editors declare that they have no competing interests.
17th International Conference on Human Retroviruses: HTLV and Related Viruses. Go to conference site.
Trois Ilets, Martinique18-21 June 2015
Page 3 of 3
-
Citation: Retrovirology 2015 12(Suppl 1):P61
-
HTLV-1 Tax targets centrosomal Cep63 protein
Citation: Retrovirology 2015 12(Suppl 1):P62 -
Are seroindeterminate western blot patterns in human T-Cell lymphotropic virus type 1 (Htlv-1) infected individuals associated with low proviral load levels?
Citation: Retrovirology 2015 12(Suppl 1):P63 -
Activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of HTLV-1 infected lymphocytes through the blood brain barrier
Citation: Retrovirology 2015 12(Suppl 1):P64 -
Analysis of Tax sequence and its nucleotide polymorphisms in HTLV-1 cases from Argentina
Citation: Retrovirology 2015 12(Suppl 1):P65 -
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P66 -
Evaluation of clinical outcome measures for HAM/TSP
Citation: Retrovirology 2015 12(Suppl 1):P67 -
CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report
Citation: Retrovirology 2015 12(Suppl 1):P68 -
Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P69 -
Baseline CD8 T-cell activation is not associated with survival in ATLL
Citation: Retrovirology 2015 12(Suppl 1):P70 -
Droplet Digital PCR for absolute quantification and determination of proviral load of HTLV-1 and 2
Citation: Retrovirology 2015 12(Suppl 1):P71 -
Nutritional status and behavioral factors of individuals with HTLV-1 and tropical spastic paraparesis (HAM / TSP)
Citation: Retrovirology 2015 12(Suppl 1):P72 -
Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P73 -
Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)
Citation: Retrovirology 2015 12(Suppl 1):P74 -
Retrospective clinic and urodynamic study in the Neurogenic Bladder Dysfunction caused by Human T Cell Lymphotrophic Virus Type 1 Associated Myelopathy / Tropical spastic paraparesis (HAM/TSP)
Citation: Retrovirology 2015 12(Suppl 1):P75 -
Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
Citation: Retrovirology 2015 12(Suppl 1):P76 -
Consequences of the association between HTLV-1 and tuberculosis
Citation: Retrovirology 2015 12(Suppl 1):P77 -
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: retrospective study in Martinique
Citation: Retrovirology 2015 12(Suppl 1):P78 -
HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)
Citation: Retrovirology 2015 12(Suppl 1):P79 -
Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event
Citation: Retrovirology 2015 12(Suppl 1):P80 -
Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa
Citation: Retrovirology 2015 12(Suppl 1):P81 -
Co-circulation of two envelope variants for both gorilla and chimpanzee Simian Foamy Virus strains among humans and apes living in Central Africa
Citation: Retrovirology 2015 12(Suppl 1):P82 -
Search for primate T-lymphotropic virus type 4 in highly exposed human populations and gorillas from Central Africa
Citation: Retrovirology 2015 12(Suppl 1):P83 -
Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors
Citation: Retrovirology 2015 12(Suppl 1):P84 -
Molecular epidemiology of HTLV-1 in Argentina
Citation: Retrovirology 2015 12(Suppl 1):P85 -
Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
Citation: Retrovirology 2015 12(Suppl 1):P86 -
DARC polymorphism that abrogates erythrocyte Duffy antigen expression influences MCP-1 plasma level in HTLV-1 infected individuals but are not associated with HAM/TSP
Citation: Retrovirology 2015 12(Suppl 1):P87 -
Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
Citation: Retrovirology 2015 12(Suppl 1):P88 -
HTLV-1-induced leukotriene B4 secretion promotes the recruitment of target cells
Citation: Retrovirology 2015 12(Suppl 1):P89 -
Expression of alternatively spliced HTLV-1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence
Citation: Retrovirology 2015 12(Suppl 1):P90 -
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms
Citation: Retrovirology 2015 12(Suppl 1):P91 -
Identification and characterization of novel NF-kB dependent genes involved in HTLV-I pathogenesis
Citation: Retrovirology 2015 12(Suppl 1):P93 -
Case report of a functional evaluation of autonomy loss of a patient with TSP/HAM in PRM unit
Citation: Retrovirology 2015 12(Suppl 1):P94 -
Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
Citation: Retrovirology 2015 12(Suppl 1):P95 -
Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy
Citation: Retrovirology 2015 12(Suppl 1):P96 -
Peptide microarray mapping of B cell epitopes on bovine leukemia virus and peptide ELISA analysis of conservation of epitopes in BLV infected Japanese cattle
Citation: Retrovirology 2015 12(Suppl 1):P97 -
Exosomes derived from HTLV-1 infected cells contain viral proteins and mRNA
Citation: Retrovirology 2015 12(Suppl 1):P98
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.3 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.004 - SNIP (Source Normalized Impact per Paper)
0.892 - SJR (SCImago Journal Rank)2023 Speed
8 days submission to first editorial decision for all manuscripts (Median)
83 days submission to accept (Median)2023 Usage
932,795 downloads
667 Altmetric mentions